- Home
- ABSI vs BCSF Comparison
ABSI vs BCSF Comparison
Compare ABSI & BCSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABSI | BCSF |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 997.8M | 838.7M |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ABSI | BCSF |
|---|---|---|
| Price | $6.53 | $12.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $6.96 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 4.5M | 329.9K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 14.61% |
| EPS Growth | ★ 10.64 | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | ★ $4,534,000.00 | N/A |
| Revenue This Year | $215.96 | N/A |
| Revenue Next Year | $319.10 | N/A |
| P/E Ratio | ★ N/A | $257.80 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.24 | $11.82 |
| 52 Week High | $7.39 | $15.84 |
Technical Indicators
Market Signals| Indicator | ABSI | BCSF |
|---|---|---|
| Relative Strength Index (RSI) | 57.46 | 44.99 |
| Support Level | $2.55 | $12.49 |
| Resistance Level | $7.06 | $13.74 |
| Average True Range (ATR) | 0.68 | 0.31 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 62.05 | 29.37 |
Price Performance
Historical ComparisonAbout ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
About BCSF Bain Capital Specialty Finance Inc.
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing in middle-market companies. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan, and others.